Teva Pharmaceutical Industries Ltd

Published Date: 14/06/2011
Category: Therapies & Markets

Research Report Decription

Teva Pharmaceutical Industries Limited - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings, detailed financials, and corporate actions, providing a 360˚ view of the company.

Features:

• Detailed information on Teva Pharmaceutical Industries Limited required for business and competitor intelligence needs
• A study of the major internal and external factors affecting Teva Pharmaceutical Industries Limited in the form of a SWOT analysis
• An in-depth view of the business model of Teva Pharmaceutical Industries Limited including a breakdown and examination of key business segments
• Five-year financial information and charts, including balance sheet, income statement, cash flows, market capitalization and multiples, and key ratios for Teva Pharmaceutical Industries Limited
• Intelligence on Teva Pharmaceutical Industries Limitednv’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
• News about Teva Pharmaceutical Industries Limited, such as business expansion, restructuring, and contract wins
• Large number of easy-to-grasp charts and graphs that present important data and key trends

Key Questions Answered:

• Gain understanding of the Teva Pharmaceutical Industries Limited and the factors that influence its strategies
• Track strategic initiatives of the company and latest corporate news and actions
• Assess Teva Pharmaceutical Industries Limited as a prospective partner, vendor or supplier
• Support sales activities by understanding your customers' businesses better
• Stay up to date on Teva Pharmaceutical Industries Limited’s business structure, strategy and prospects

Companies Mentioned:

Teva Pharmaceutical Industries

Paper Highlights:

Teva Pharmaceutical Industries (Teva) is the world's leading generic pharmaceutical company. Teva is engaged in the development, production and marketing of generic, proprietary branded pharmaceuticals and active pharmaceutical ingredients. The company conducts its operations in North America, Europe, Latin America, Asia and Israel. Teva is headquartered in Petach Tikva, Israel and employed 39,660 people as of December 31, 2010. The company recorded revenues of $16,121 million during the financial year (FY) ended December 2010, an increase of 16% over FY2009. The operating profit of the company was $3,871 million during FY2010, an increase of 61% over FY2009. The net profit was $3,331 million in FY2010, an increase of 66.6% over FY2009.